LEVOPHED(R) NOREPINEPHRINE BITARTRATE
Drug Details
- Generic Name
- LEVOPHED(R) NOREPINEPHRINE BITARTRATE
- Brand Names
- LEVOPHED(R) NOREPINEPHRINE BITARTRATE
- Application Number
- NDA007513
- Sponsor
- HF Acquisition Co LLC, DBA HealthFirst
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- NOREPINEPHRINE BITARTRATE
Indications and Usage
INDICATIONS & USAGE For blood pressure control in certain acute hypotensive states (e.g., pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesthesia, myocardial infarction, septicemia, blood transfusion, and drug reactions). As an adjunct in the treatment of cardiac arrest and profound hypotension.
Warnings
WARNINGS LEVOPHED should be used with extreme caution in patients receiving monoamine oxidase inhibitors (MAOI) or antidepressants of the triptyline or imipramine types, because severe, prolonged hypertension may result. LEVOPHED Bitartrate Injection contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.